Evonik (Germany) is one of the world leaders in specialty chemicals. 80 percent of sales come from leading market positions. Evonik focuses its R&D activities and investments on high-growth megatrends, especially health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative process and integrated technology platforms.
In 2013 Evonik’s 33,000 employees generated sales of €12.9 billion and an operating result (adjusted EBITDA) of €2.0 billion. Evonik is active in over 100 countries around the world, and 76 percent of sales are generated outside Germany.